Naramig (Naratriptan)

Naratriptan works by selectively activating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This causes vasoconstriction of dilated vessels and blocks the release of neuropeptides that trigger migraine pain.

The specific dose of Naramig is determined by the prescribing healthcare professional based on the individual’s clinical condition, severity of migraine, and response to therapy. Patients should follow the prescriber’s instructions exactly.

The safety of naratriptan in pregnancy and lactation has not been fully established. Healthcare providers should weigh potential benefits against possible risks and discuss alternative options with pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naramig (naratriptan) belongs to the triptan class, which is generally more migraine‑specific than non‑specific analgesics. Compared with sumatriptan, naratriptan has a longer half‑life, offering a more extended period of symptom relief, but individual response may vary.

Store Naramig tablets at room temperature below 25 °C, in the original blister pack, and protect them from moisture and direct sunlight. Keep the medication out of reach of children and do not use after the expiry date.

Naramig is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the first sign of a migraine attack. Patients should not crush, chew, or split the tablet unless directed by a healthcare professional.

Serious risks include chest pain or tightness, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Any sudden cardiovascular symptoms or signs of an allergic reaction require immediate medical attention.

Naramig should be avoided in patients with uncontrolled hypertension, a history of ischemic heart disease, severe hepatic impairment, or known hypersensitivity to naratriptan or any tablet excipients. It is also contraindicated when used with certain ergot or other triptan medications.